Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunocompromised Patients with Protracted COVID-19: a Review of “Long Persisters”
M. Veronica Dioverti, Sonsoles Salto‐Alejandre, Ghady Haidar
Current Transplantation Reports (2022) Vol. 9, Iss. 4, pp. 209-218
Open Access | Times Cited: 60

Showing 26-50 of 60 citing articles:

Prolonged COVID-19 Pneumonia in Patients with Hematologic Malignancies: Clinical Significance and Serial CT Findings
Dae Hee Han, Raeseok Lee, Gi June Min, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2701-2701
Open Access
Ensitrelvir in Hospitalized Patients with SARS-CoV-2 During the Omicron Epidemic: A Single-Center Observational Study
Masaya Yamato, M. Kinoshita, Yuki Yoshida, et al.
Infectious Diseases and Therapy (2025)
Open Access
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2–Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients
Ghady Haidar, Jana L. Jacobs, Kailey Hughes Kramer, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 5, pp. 696-702
Open Access | Times Cited: 9
SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency
Yijia Li, Manish C. Choudhary, James Regan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Immune Status and SARS-CoV-2 Viral Dynamics
Yijia Li, Carlee Moser, Evgenia Aga, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_2, pp. S111-S116
Open Access | Times Cited: 9
Persistent SARS-CoV-2 infection in patients with B-cell deficiency: a case series of successful antiviral treatment of four patients
Lisa Faxén, Marie Edvinsson
Upsala Journal of Medical Sciences (2023) Vol. 128
Open Access | Times Cited: 9
Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients
Sabina Herrera, José María Aguado, Francisco Javier Candel, et al.
Transplantation Reviews (2023) Vol. 37, Iss. 4, pp. 100788-100788
Closed Access | Times Cited: 8
Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID‐19 infection at an ambulatory cancer center
Eduardo Sanchez, Elizabeth M. Krantz, Leah M. Yoke, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 3
Relapse of COVID-19 and Viral Evolution in a Patient With Good Syndrome: A Case Report
Mika Iwasaki, Masao Hashimoto, Junko S. Takeuchi, et al.
Cureus (2024)
Open Access | Times Cited: 3
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review
Paul Kinsella, Michael A. Moso, C. Orla Morrissey, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Open Access | Times Cited: 3
Interstitial lung changes and persistent COVID‐19 in a patient with follicular lymphoma: A case report
Makiko Yomota, Masaru Tanaka, Takayuki Kobayashi, et al.
Respirology Case Reports (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 2
Re: Persistent COVID-19 in immunocompromised patients—Israeli Society of Infectious Diseases consensus statement on diagnosis and management by Meijer et al.
Alberto Enrico Maraolo, Nicola Schiano Moriello, Ivan Gentile
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 9, pp. 1209-1210
Closed Access | Times Cited: 2
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19
Kanal Singh, Joseph M. Rocco, Véronique Nussenblatt
Seminars in Hematology (2024) Vol. 61, Iss. 5, pp. 321-332
Closed Access | Times Cited: 2
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection
Michael Schoefbaenker, Theresa Günther, Eva U. Lorentzen, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 10, pp. e1012624-e1012624
Open Access | Times Cited: 2
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients
Chiara Sepulcri, Claudia Bartalucci, Małgorzata Mikulska
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 506-517
Closed Access | Times Cited: 2
Dual antiviral therapy in haematological patients with protracted SARS‐CoV‐2 infection
Francesco Peracchi, Marco Merli, C. Rogati, et al.
British Journal of Haematology (2023) Vol. 201, Iss. 6
Open Access | Times Cited: 6
The pathophysiology of postacute sequelae of COVID-19 (PASC): Possible role for persistent inflammation
Gailen D. Marshall
Asia Pacific Allergy (2023) Vol. 13, Iss. 2, pp. 77-84
Open Access | Times Cited: 6
Convalescent plasma in patients receiving Rituximab or Ocrelizumab for Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder with COVID-19: A Multicenter Retrospective Study
Tanguy Dequidt, Quentin Richier, Céline Louapre, et al.
International Journal of Infectious Diseases (2024) Vol. 151, pp. 107323-107323
Closed Access | Times Cited: 2
Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient
Caroline E. Mullis, Madeleine R. Heldman, Nathan C. Bahr, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Closed Access | Times Cited: 1
Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylation
Savanna S. Skeeters, Kamal Bagale, Galina A. Stepanyuk, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101301-101301
Closed Access | Times Cited: 1
Prevalencia y factores de riesgo en inmunodeprimidos asociados a infección por covid-19
Javier Martín Reyes-Baque, Bryan Steeven Bazurto-Acuña, Allyson Melissa García- Soledispa
MQRInvestigar (2024) Vol. 8, Iss. 3, pp. 2139-2157
Open Access | Times Cited: 1
Convalescent Plasma for Immunocompromised Patients
Shmuel Shoham
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Protracted coronavirus disease 2019 after chimeric antigen receptor-T cell therapy successfully treated with sequential multidrug therapy
Masahiro Yamashita, Hisao Higo, Nobuharu Fujii, et al.
Respiratory Medicine Case Reports (2024) Vol. 51, pp. 102104-102104
Open Access | Times Cited: 1
Use of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) strand-specific assay to evaluate for prolonged viral replication >20 days from illness onset
J Ferguson, Ralph Tayyar, Gustavo Contreras, et al.
Infection Control and Hospital Epidemiology (2023) Vol. 44, Iss. 12, pp. 2078-2080
Closed Access | Times Cited: 1
Ensitrelvir Fumaric Acid in Patients with SARS-CoV-2: A Retrospective Chart Review
Masaya Yamato, Masahiro Kinoshita, Shogo Miyazawa, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Scroll to top